(S)-(+)-modafinil
| |
Names | |
---|---|
IUPAC name
2-[(S)-benzhydrylsulfinyl]acetamide
| |
Identifiers | |
CAS Number
|
|
3D model (JSmol)
|
|
ChEBI |
|
ChEMBL |
|
ChemSpider |
|
ECHA InfoCard | 100.234.492 |
EC Number |
|
PubChem CID
|
|
UNII |
|
CompTox Dashboard (EPA)
|
|
InChI
| |
SMILES
| |
Properties | |
Chemical formula
|
C15H15NO2S |
Molar mass | 273.35 g·mol−1 |
Hazards | |
GHS labelling:[1] | |
Pictograms
|
|
Signal word
|
Warning |
Hazard statements
|
H302 |
Precautionary statements
|
P264, P270, P301+P317, P330, P501 |
Related compounds | |
Related compounds
|
Modafinil, Armodafinil |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references
|
Esmodafinil (also known as (S)-modafinil or (+)-Modafinil) is the enantiopure isolation of the (S) enantiomer of modafinil. Unlike armodafinil, esmodafinil has never been marketed on its own.[2]
Esmodafinil is suspected to be less clinically useful for treating conditions that modafinil and armodafinil are marketed for, such as narcolepsy, sleep-shift work disorder, and obstructive sleep apnea.[3]